Virios Therapeutics Llc Analysis
| VIRIDelisted Stock | USD 3.95 0.00 0.00% |
Virios Therapeutics Llc is overvalued with Real Value of 3.48 and Hype Value of 3.96. The main objective of Virios Therapeutics delisted stock analysis is to determine its intrinsic value, which is an estimate of what Virios Therapeutics Llc is worth, separate from its market price. There are two main types of Virios Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Virios Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Virios Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
Virios |
Virios Stock Analysis Notes
The company has Price to Book (P/B) ratio of 1.37. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Virios Therapeutics Llc recorded a loss per share of 5.75. The entity had not issued any dividends in recent years. The firm had 1:25 split on the 9th of October 2024. Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia. Virios Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. For more information please call Gregory Duncan at 866 620 8655 or visit https://www.virios.com.Virios Therapeutics Llc Investment Alerts
| Virios Therapeutics is now traded under the symbol DWTX. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Virios Therapeutics is not yet fully synchronised with the market data | |
| Virios Therapeutics had very high historical volatility over the last 90 days | |
| Virios Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (5.3 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Virios Therapeutics Llc currently holds about 7.7 M in cash with (4.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.92. |
Virios Therapeutics Llc Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Virios Therapeutics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Virios Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 172.1 K.Virios Therapeutics Llc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Virios Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Virios Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Virios Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Virios Therapeutics Outstanding Bonds
Virios Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Virios Therapeutics Llc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Virios bonds can be classified according to their maturity, which is the date when Virios Therapeutics Llc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| VISA INC 365 Corp BondUS92826CAJ18 | View | |
| VISA INC 275 Corp BondUS92826CAH51 | View | |
| VISA INC 43 Corp BondUS92826CAF95 | View | |
| VISA INC 415 Corp BondUS92826CAE21 | View | |
| VISA INC 315 Corp BondUS92826CAD48 | View |
Virios Therapeutics Predictive Daily Indicators
Virios Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Virios Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Virios Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Virios Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Virios shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Virios Therapeutics. By using and applying Virios Stock analysis, traders can create a robust methodology for identifying Virios entry and exit points for their positions.
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia. Virios Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Virios Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Virios Stock
If you are still planning to invest in Virios Therapeutics Llc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Virios Therapeutics' history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |